← All indications
Infarction, Middle Cerebral Artery
NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
Drugs by status
Phase 3 trials (4)
Phase 2 trials (8)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (14)
- Celgene
- Merck
- Cellonis Biotechnology Co. Ltd.
- Huazhong University of Science and Technology
- Guangzhou Medical University
- National University of Malaysia
- University Hospital Center of Martinique
- Badalona Hospital Germans Trias i Pujol
- Southern Medical University
- Centre Hospitalier Universiatire de Martinique
- UKM Medical Centre
- Second People's Hospital of Nanhai District of Foshan
- Cytopeutics Pte. Ltd.
- China Medical University
Organization Involved with Phase 1 Indications (1)